ACADL
Long-chain specific acyl-CoA dehydrogenase, mitochondrial
Also known as: ACAD4, ACADL_HUMAN, LCAD
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28330
- Gene
- ACADL
- Ensembl
- ENSG00000115361
- Chromosome
- 2
- Canonical length
- 430 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family, which is a family of mitochondrial flavoenzymes involved in fatty acid and branched chain amino-acid metabolism. This protein is one of the four enzymes that catalyze the initial step of mitochondrial beta-oxidation of straight-chain fatty acid. Defects in this gene are the cause of long-chain acyl-CoA dehydrogenase (LCAD) deficiency, leading to nonketotic hypoglycemia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
430 residues, UniProt reviewed canonical sequence.
>P28330|ACADL
1 MAARLLRGSL RVLGGHRAPR QLPAARCSHS GGEERLETPS AKKLTDIGIR RIFSPEHDIF
61 RKSVRKFFQE EVIPHHSEWE KAGEVSREVW EKAGKQGLLG VNIAEHLGGI GGDLYSAAIV
121 WEEQAYSNCS GPGFSIHSGI VMSYITNHGS EEQIKHFIPQ MTAGKCIGAI AMTEPGAGSD
181 LQGIKTNAKK DGSDWILNGS KVFISNGSLS DVVIVVAVTN HEAPSPAHGI SLFLVENGMK
241 GFIKGRKLHK MGLKAQDTAE LFFEDIRLPA SALLGEENKG FYYIMKELPQ ERLLIADVAI
301 SASEFMFEET RNYVKQRKAF GKTVAHLQTV QHKLAELKTH ICVTRAFVDN CLQLHEAKRL
361 DSATACMAKY WASELQNSVA YDCVQLHGGW GYMWEYPIAK AYVDARVQPI YGGTNEIMKE
421 LIAREIVFDKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACADL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- liver: 26 nTPM
- blood vessel: 25 nTPM
- pancreas: 19 nTPM
- kidney: 19 nTPM
- thyroid gland: 17 nTPM
- prostate: 14 nTPM
Single-cell type
- prostatic glandular cells: 318 nCPM
- thymic myoid cells: 166 nCPM
- leydig cells: 164 nCPM
- peritubular myoid cells: 162 nCPM
- adipocytes: 140 nCPM
- alveolar cells type 2: 127 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 1.2 nTPM
- choroid plexus: 0.5 nTPM
- white matter: 0.5 nTPM
- amygdala: 0.4 nTPM
- cerebral cortex: 0.3 nTPM
- midbrain: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.86
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carnitine metabolic process, CoA-linked
- fatty acid beta-oxidation using acyl-CoA dehydrogenase
- lipid catabolic process
- long-chain fatty acid catabolic process
- negative regulation of fatty acid biosynthetic process
- negative regulation of fatty acid oxidation
- positive regulation of cold-induced thermogenesis
- regulation of cholesterol metabolic process
- temperature homeostasis
- carnitine catabolic process
Molecular functions
- flavin adenine dinucleotide binding
- long-chain fatty acyl-CoA dehydrogenase activity
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acyl-CoA dehydrogenase, conserved site
- Acyl-CoA dehydrogenase/oxidase, middle domain
- Acyl-CoA dehydrogenase/oxidase, C-terminal
- Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily
- Acyl-CoA dehydrogenase/oxidase, N-terminal
- Acyl-CoA dehydrogenase-like, C-terminal
- Acyl-CoA dehydrogenase/oxidase, N-terminal domain superfamily
- Acyl-CoA oxidase/dehydrogenase, middle domain superfamily
- Acyl-CoA dehydrogenase, C-terminal domain
- Acyl-CoA dehydrogenase, middle domain
- Acyl-CoA dehydrogenase, N-terminal domain
- Long-chain specific acyl-CoA dehydrogenase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACADL as an antibody target. Whether an autoantibody or antibody against ACADL could matter depends on whether native ACADL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACADL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACADL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...